Induction treatment before surgery for non-small cell lung cancer

Lung Cancer

Volumn 42, Issue 2 SUPPL., 2003, Pages 9-14

  Eberhardt, W E ^a   Albain, K S ^b   Pass, H ^c   Putnam, J B ^d   Gregor, A ^e   Assamura, H ^f   Mornex, F ^g   Senan, S ^h   Belderbos, J ⁱ   Westeel, V ^j   Thomas, M ^k   Van Schil, P ^l   Vansteenkiste, J ^m   Manegold, C ⁿ   Mirimanoff, R O ^o   Stuschke, M ^p   Pignon, J ^q   Rocmans, P ^r   Shepherd, F A ^s  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Edinburgh Cancer Centre   (United Kingdom)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^j UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^k UNIVERSITY OF MÜNSTER   (Germany)

^l Dept of Thorac/Vascular Surgery ^*  (Belgium)

^m UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

^o LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^p UNIVERSITY OF DUISBURG ESSEN   (Germany)

^q INSTITUT GUSTAVE ROUSSY   (France)

^r ERASME HOSPITAL   (Belgium)

^s PRINCESS MARGARET HOSPITAL   (Canada)

more..

Author keywords

Chemoradiation; Chemotherapy; Induction therapy; Lung cancer, non small cell; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL STUDY; CONFERENCE PAPER; HEALTH STATUS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZATION; STANDARD;

EID: 10744223986     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00300-3     Document Type: Conference Paper

References (23)

1. Klastersky J., Burkes R., Choi N., et al. Induction therapy for NSCLC. Lung Cancer. 7:1991;15-17.
2. Green M.R., Ginsberg R., Ardizzoni A., et al. Induction therapy for stage III NSCLC: a consensus report. Lung Cancer. 11:(Suppl. 3):1994;S9-S10.
3. Perry M.C., Deslauriers J., Albain K.S., et al. Induction treatment for resectable non-small-cell lung cancer. Lung Cancer. 17:(Suppl. 1):1997;S15-18.
4. Albain K., Rusch V., Crowley J., et al. Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805. Proc. Am. Soc. Clin. Oncol. 18:1999;A1801.
5. Burkes R., Shepherd F., Ginsberg R., et al. Induction chemotherapy with MVP in patients with stage IIIa (T1-3, N2, M0) unresectable non small cell lung cancer (NSCLC): the Toronto experience. Proc. Am. Soc. Clin. Oncol. 19:2000;A1941.
6. Eberhardt W., Wilke H., Stamatis M., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in advanced non-small-cell lung cancer: mature results of a phase II trial. J. Clin. Oncol. 16:1998;622-634.
7. Choi N.C., Carey R.W., Daly W., et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J. Clin. Oncol. 15:1997;712-722.
8. Grunenwald D.H., Andre F., Le Pechoux C., et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 122:(4):2001;796-802.
9. Thomas M., Rübe C., Semik M., et al. Chemotherapy and subsequent twice-daily chemoradiation before surgery in stage III non-small cell lung cancer: impact of tumor regression on survival. J. Clin. Oncol. 17:1999;1185-1193.
10. De Boer R.H., Smith I.E., Pastorino U., et al. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial. Br. J. Cancer. 79:(9-10):1999;1514-1518.
11. Shepherd F.A., Johnston M.R., Payne D., et al. Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Br. J. Cancer. 78:(5):1998;683-685.
12. Johnstone D.W., Byhardt R.W., Ettinger D., et al. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 54:(2):2002;365-369.
13. Rendina E.A., Venuta F., De Giacomo T., et al. Induction chemotherapy for T4 centrally located non-small cell lung cancer. J Thorac. Cardiovasc. Surg. 117:1999;225-233.
14. Mateu-Navarra R.T., Rami-Porta R., Bastus-Piulats R., et al. Remediastinoscopy after induction chemotherapy in non-small-cell lung cancer. Ann. Thorac. Surg. 70:2000;391-395.
15. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Ann. Oncol. 9:(11):1998;1193-1198.
16. Van Schil P., van der Schoot J., Poniewierski J., et al. Re-mediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer. 37:2002;281-285.
17. Stuschke M., Eberhardt W., Pöttgen C., et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuro-psychologic effects. J. Clin. Oncol. 17:1999;2700.
18. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J. Thorac. Cardiovasc. Surg. 121:2001;472-483.
19. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer. 26:1999;7-14.
20. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer. 21:1998;1-6.
21. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J. Clin. Oncol. 20:(1):2002;247-253.
22. Pisters K.M., Ginsberg R.J., Giroux D.J., et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach - Bimodality Lung Oncology Team. J. Thorac. Cardiovasc. Surg. 119:2000;429-439.
23. Andre F., Grunenwald D., Pignon J.P., et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J. Clin. Oncol. 18:2000;2981-2989.